Amlin PLC
05 November 2002
For immediate release
AMLIN plc
SHARE CAPITAL UPDATE
On 11 October 2002 Lloyd's approved the application by Amlin plc ('Amlin') and
its wholly-owned subsidiary, Amlin Underwriting Limited, to proceed with the
compulsory acquisition of all of the outstanding capacity on Syndicate 2001
which Amlin and its subsidiaries does not hold and has not acquired pursuant to
the capacity offer made on 2 August 2002.
Pursuant to this Amlin has today allotted a further 82,670 ordinary shares of
25p each, in addition to those already announced. The shares will rank pari
passu in all respects with the existing issued ordinary share capital of the
Company.
Amlin has also issued 52,134 shares resulting from recent exercises of share
options, which are included within current block listings granted by the UK
Listing Authority and the London Stock Exchange.
The issued share capital of Amlin is now 387,979,843 ordinary shares of 25p
each.
5 November 2002
Enquiries:
Charles Pender 020 7746 1008
Secretary
Amlin plc
This information is provided by RNS
The company news service from the London Stock Exchange LILEIIF
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.